Literature DB >> 1381562

Assessment of proliferative activity in ovarian neoplasms by flow and static cytometry. Correlation with prognostic features.

P C Huettner1, D S Weinberg, J M Lage.   

Abstract

We undertook a prospective flow and static cytometric study of proliferative activity in 74 malignant, borderline and benign ovarian neoplasms. Proliferative activity as assessed by S phase fraction (SPF), and immunostaining of tissue sections with Ki-67 antibody was compared with prognostically important clinicopathologic features. Malignant neoplasms had higher median percentage Ki-67 staining (27.6%) than borderline (12.3%) and benign (2.7%) tumors (P less than 0.05). Percentage Ki-67 staining correlated with SPF, DNA index, architectural grade, nucleolar grade, and mitotic count in malignant tumors; with nucleolar grade in benign tumors and with none of these variables in borderline tumors. Similarly, malignant neoplasms had a higher median SPF (11.5%) than borderline (3.4%) and benign (2.9%) neoplasms (P less than 0.05). In malignant neoplasms, SPF correlated with percentage Ki-67 staining, DNA index, age, and stage, but with none of these in borderline or benign neoplasms.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1381562      PMCID: PMC1886709     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  40 in total

1.  Analysis of PCP-data to determine the fraction of cells in the various phases of cell cycle.

Authors:  H Baisch; W Göhde; W A Linden
Journal:  Radiat Environ Biophys       Date:  1975-06-13       Impact factor: 1.925

2.  Ki-67 and grading of malignant fibrous histiocytomas.

Authors:  R J Zehr; T W Bauer; K E Marks; A Weltevreden
Journal:  Cancer       Date:  1990-11-01       Impact factor: 6.860

Review 3.  Ploidy, proliferative activity and prognosis. DNA flow cytometry of solid tumors.

Authors:  D E Merkel; W L McGuire
Journal:  Cancer       Date:  1990-03-01       Impact factor: 6.860

4.  Ovarian granulosa-stromal cell tumors are characterized by trisomy 12.

Authors:  J A Fletcher; Z Gibas; K Donovan; A Perez-Atayde; D Genest; C C Morton; J M Lage
Journal:  Am J Pathol       Date:  1991-03       Impact factor: 4.307

5.  Tumor proliferative fraction in solid malignant neoplasms. A comparative study of Ki-67 immunostaining and flow cytometric determinations.

Authors:  A A Sahin; J Y Ro; A K el-Naggar; P L Wilson; K Teague; M Blick; A G Ayala
Journal:  Am J Clin Pathol       Date:  1991-10       Impact factor: 2.493

6.  The prognostic significance of nuclear DNA content in malignant epithelial tumors of the ovary.

Authors:  R J Brescia; R A Barakat; U Beller; G Frederickson; M J Suhrland; N Dubin; R I Demopoulos
Journal:  Cancer       Date:  1990-01-01       Impact factor: 6.860

7.  Steroid receptors and Ki-67 reactivity in ovarian cancer and in normal ovary: correlation with DNA flow cytometry, biochemical receptor assay, and patient survival.

Authors:  J Isola; O P Kallioniemi; J M Korte; T Wahlström; R Aine; M Helle; H Helin
Journal:  J Pathol       Date:  1990-12       Impact factor: 7.996

8.  Importance of histologic grading in the prognosis of epithelial ovarian carcinoma.

Authors:  B Sorbe; B Frankendal; B Veress
Journal:  Obstet Gynecol       Date:  1982-05       Impact factor: 7.661

9.  The prognostic value of Ki67 immunostaining in non-Hodgkin's lymphoma.

Authors:  P A Hall; M A Richards; W M Gregory; A J d'Ardenne; T A Lister; A G Stansfeld
Journal:  J Pathol       Date:  1988-03       Impact factor: 7.996

10.  Comparative assessment of proliferation and DNA content in breast carcinoma by image analysis and flow cytometry.

Authors:  A E Dawson; J A Norton; D S Weinberg
Journal:  Am J Pathol       Date:  1990-05       Impact factor: 4.307

View more
  5 in total

1.  The proliferation markers Ki-67/MIB-1, phosphohistone H3, and survivin may contribute in the identification of aggressive ovarian carcinomas.

Authors:  Guro Aune; Astrid K Stunes; Solveig Tingulstad; Oyvind Salvesen; Unni Syversen; Sverre H Torp
Journal:  Int J Clin Exp Pathol       Date:  2011-06-11

2.  Mutant BRAF induces DNA strand breaks, activates DNA damage response pathway, and up-regulates glucose transporter-1 in nontransformed epithelial cells.

Authors:  Jim Jinn-Chyuan Sheu; Bin Guan; Fuu-Jen Tsai; Erin Yi-Ting Hsiao; Chih-Mei Chen; Raquel Seruca; Tian-Li Wang; Ie-Ming Shih
Journal:  Am J Pathol       Date:  2012-01-05       Impact factor: 4.307

3.  Allelic loss at 19q12 and Xq11-12 predict an adverse clinical outcome in patients with mucinous ovarian tumours of low malignant potential.

Authors:  K Nakayama; Y Takebayashi; K Hata; R Fujiwaki; K Iida; M Fukumoto; K Miyazaki
Journal:  Br J Cancer       Date:  2004-03-22       Impact factor: 7.640

4.  Positron emission tomography in ovarian cancer: 18F-deoxy-glucose and 16alpha-18F-fluoro-17beta-estradiol PET.

Authors:  Yoshio Yoshida; Tetsuji Kurokawa; Tetuya Tsujikawa; Hidehiko Okazawa; Fumikazu Kotsuji
Journal:  J Ovarian Res       Date:  2009-06-16       Impact factor: 4.234

5.  Predictive and prognostic protein biomarkers in epithelial ovarian cancer: recommendation for future studies.

Authors:  Cécile Le Page; David G Huntsman; Diane M Provencher; Anne-Marie Mes-Masson
Journal:  Cancers (Basel)       Date:  2010-05-26       Impact factor: 6.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.